| Ytd | 31.32% | |
| 1y | -37.30% |
| Open | 1.36 | Prev Close | 1.38 | Low | 1.36 | High | 1.40 | Mkt Cap | 7.43M |
| Vol | 21.20K | Avg Vol | 930.43K | EPS | -1.47 | P/E | N/A | Forward P/E | -0.75 |
| Beta | 0.96 | Short Ratio | 0.12 | Inst. Own | 8.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-23 | 50-d Avg | 1.53 | 200-d Avg | 1.19 | 1yr Est | 20.00 |
INM News
InMed Pharmaceuticals (NASDAQ: INM - Get Free Report) and Reviva Pharmaceuticals (NASDAQ: RVPH - Get
Mentari Therapeutics, a privately held biotechnology enterprise dedicated to preventing migraines, h
Mentari Therapeutics secures $200 million in private financing before merging with InMed Pharmaceuti
Gainers Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 108.6% to $14.77 during Wednesday'
Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday&#
WALTHAM, Mass., July 22, 2026 /PRNewswire/ -- Mentari Therapeutics, Inc. ("Mentari"), a privately-he
Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Gr
Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-mark
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Vancouver, British Columbia and San Francisco, California--(Newsfile Corp. - July 6, 2026) - InMed P
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Vancouver, British Columbia--(Newsfile Corp. - June 4, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: I
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RAMP, NEE, D, and
NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
InMed Pharmaceuticals Inc. (INM) M&A Call Prepared Remarks Transcript
NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & A
BALA CYNWYD, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it i
/C O R R E C T I O N -- InMed Pharmaceuticals/ PR Newswire VANCOUVER, BC and SAN FRANCISCO, May 19,
US stocks down, Nasdaq drops 200 points. Dow -0.35% at 49,512.48, Nasdaq -0.93% at 25,849.08, S&
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of InMed Pharmaceuticals,
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merge
US stocks fall, Dow Jones down 0.34% & NASDAQ down 0.41% in morning trading. Home Depot reports
InMed Pharmaceuticals Inc. (NASDAQ:INM) shares are up during Tuesday's premarket session, as the com
InMed agrees to merge with Mentari Therapeutics to advance migraine drug candidates backed by $290 m
About the Proposed TransactionUnder the terms of the merger agreement, as of the closing of the prop
Upon consummation of the transaction contemplated by the Agreement, the combined entity will operate
Mentari's parallel lead programs target validated, complementary pathways with potential to address
Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: I
Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Ot
AI-related stocks including industry leaders like Nvidia (NASDAQ: NVDA), cloud computing, and cybers
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholder
Gainers ReShape Lifesciences Inc. (NASDAQ: RSLS) shares surged 62.8% to $0.3348 in pre-market tra